A far downstream enhancer for murine Bcl11b controls its T-cell specific expression

Blood

Volumn 122, Issue 6, 2013, Pages 902-911

  Li, Long ^a   Zhang, Jingli A ^a,c   Dose, Marei ^b,d   Kueh, Hao Yuan ^a   Mosadeghi, Ruzbeh ^a   Gounari, Fotini ^b   Rothenberg, Ellen V ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c GENENTECH INC   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; ENHANCER REGION; GENE ACTIVATION; GENE BCL11B; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; T LYMPHOCYTE; TRANSCRIPTION INITIATION SITE; ANIMAL; CELL LINEAGE; CPG ISLAND; CYTOLOGY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; MOUSE; REPORTER GENE;

BCL11B PROTEIN, MOUSE; HISTONE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANIMALS; CELL LINEAGE; CPG ISLANDS; DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; HEMATOPOIETIC STEM CELLS; HISTONES; MICE; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84886909517     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-447839     Document Type: Article

References (48)

1. Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science. 2010; 329(5987):89-93.
2. Ikawa T, Hirose S, Masuda K, et al. An essential developmental checkpoint for production of the T cell lineage. Science. 2010;329(5987):93-96.
3. Li P, Burke S, Wang J, et al. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science. 2010;329(5987):85-89.
4. Inoue J, Kanefuji T, Okazuka K, Watanabe H, Mishima Y, Kominami R. Expression of TCR a b partly rescues developmental arrest and apoptosis of a b T cells in Bcl11b-/-mice. J Immunol. 2006;176(10):5871-5879.
5. Albu DI, Feng D, Bhattacharya D, Jenkins NA, Copeland NG, Liu P, Avram D. BCL11B is required for positive selection and survival of double-positive thymocytes. J Exp Med. 2007; 204(12):3003-3015.
6. Zhang S, Rozell M, Verma RK, et al. Antigenspecific clonal expansion and cytolytic effector function of CD81 T lymphocytes depend on the transcription factor Bcl11b. J Exp Med. 2010; 207(8):1687-1699.
7. Vanvalkenburgh J, Albu DI, Bapanpally C, et al. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J Exp Med. 2011;208(10): 2069-2081.
8. Tydell CC, David-Fung ES, Moore JE, Rowen L, Taghon T, Rothenberg EV. Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway. J Immunol. 2007;179(1):421-438.
9. Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell. 2012;149(2):467-482.
10. Wakabayashi Y, Inoue J, Takahashi Y, et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in g-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun. 2003;301(2):598-603.
11. MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG. Activation of HOX11L2 by juxtaposition with 39-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer. 2003;37(1):84-91.
12. Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1; q32.2). Cancer Res. 2003;63(17):5329-5334.
13. MacLeod RA, Nagel S, Drexler HG. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia. Cancer Genet Cytogenet. 2004;153(1):88-89.
14. Su XY, Della-Valle V, Andre-Schmutz I, et al. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood. 2006;108(13):4198-4201.
15. Nagel S, Scherr M, Kel A, et al. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 39-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res. 2007;67(4):1461-1471.
16. Su XY, Busson M, Della Valle V, et al. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2004;41(3):243-249.
17. Zarnegar MA, Chen J, Rothenberg EV. Cell-typespecific activation and repression of PU.1 by a complex of discrete, functionally specialized cisregulatory elements. Mol Cell Biol. 2010;30(20): 4922-4939.
18. Zarnegar MA, Rothenberg EV. Ikaros represses and activates PU.1 cell-type-specifically through the multifunctional Sfpi1 URE and a myeloid specific enhancer. Oncogene. 2012;31(43): 4647-4654.
19. Dekker J. The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat Methods. 2006;3(1):17-21.
20. Hagège H, Klous P, Braem C, et al. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc. 2007;2(7): 1722-1733.
21. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 2005;33(4):e36.
22. Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 2003;13(3):476-484.
23. David-Fung ES, Butler R, Buzi G, et al. Transcription factor expression dynamics of early T-lymphocyte specification and commitment. Dev Biol. 2009;325(2):444-467.
24. Germar K, Dose M, Konstantinou T, et al. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci USA. 2011;108(50):20060-20065.
25. Yu M, Mazor T, Huang H, et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell. 2012; 45(3):330-343.
26. Weber BN, Chi AW, Chavez A, Yashiro-Ohtani Y, Yang Q, Shestova O, Bhandoola A. A critical role for TCF-1 in T-lineage specification and differentiation. Nature. 2011;476(7358):63-68.
27. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415-428.
28. Maier H, Ostraat R, Gao H, et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol. 2004;5(10): 1069-1077.
29. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol. 2003;4(3):235-240.
30. Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010; 467(7313):338-342.
31. Taghon T, Yui MA, Rothenberg EV. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat Immunol. 2007;8(8):845-855.
32. Franco CB, Scripture-Adams DD, Proekt I, et al. Notch/Delta signaling constrains reengineering of pro-T cells by PU.1. Proc Natl Acad Sci USA. 2006;103(32):11993-11998.
33. Lin YC, Jhunjhunwala S, Benner C, et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol. 2010;11(7):635-643.
34. Barski A, Cuddapah S, Cui K, et al. Highresolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823-837.
35. Myers R, Stamatoyannopoulos J, Snyder M, et al; ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011;9(4):e1001046.
36. Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465(7295):182-187.
37. Zhang J, Jackson AF, Naito T, et al. Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat Immunol. 2012; 13(1):86-94.
38. Göttgens B, Broccardo C, Sanchez MJ, et al. The scl 118/19 stem cell enhancer is not required for hematopoiesis: identification of a 59 bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. Mol Cell Biol. 2004;24(5):1870-1883.
39. Sekimata M, Pérez-Melgosa M, Miller SA, et al. CCCTC-binding factor and the transcription factor T-bet orchestrate T helper 1 cell-specific structure and function at the interferon-g locus. Immunity. 2009;31(4):551-564.
40. Chaumeil J, Skok JA. The role of CTCF in regulating V(D)J recombination. Curr Opin Immunol. 2012;24(2):153-159.
41. Dixon JR, Selvaraj S, Yue F, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012; 485(7398):376-380.
42. Gutierrez A, Kentsis A, Sanda T, et al. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood. 2011;118(15): 4169-4173.
43. Yoshikai Y, Sato T, Morita S, et al. Effect of Bcl11b genotypes and g-radiation on the development of mouse thymic lymphomas. Biochem Biophys Res Commun. 2008;373(2): 282-285.
44. Lettice LA, Heaney SJ, Purdie LA, et al. A longrange Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet. 2003; 12(14):1725-1735.
45. Amano T, Sagai T, Tanabe H, Mizushina Y, Nakazawa H, Shiroishi T. Chromosomal dynamics at the Shh locus: limb budspecific differential regulation of competence and active transcription. Dev Cell. 2009;16(1): 47-57.
46. Jeong Y, El-Jaick K, Roessler E, Muenke M, Epstein DJ. A functional screen for sonic hedgehog regulatory elements across a 1 Mb interval identifies long-range ventral forebrain enhancers. Development. 2006;133(4): 761-772.
47. Hosoya-Ohmura S, Lin YH, Herrmann M, et al. An NK and T cell enhancer lies 280 kilobase pairs 39 to the Gata3 structural gene. Mol Cell Biol. 2011;31(9):1894-1904.
48. Qin Y, Kong LK, Poirier C, Truong C, Overbeek PA, Bishop CE. Long-range activation of Sox9 in Odd Sex (Ods) mice. Hum Mol Genet. 2004; 13(12):1213-1218.